Insulin Food Supplement for Preterm Infants

2014-07-24 14:06:45 | BioPortfolio


GENERAL:The study will evaluate the effect of insulin food supplement on preterm infants, born between 26-33 weeks of pregnancy, weighing over 750 grams, who meet the inclusion and exclusion criteria established in this protocol. The study will aim to determine whether an oral insulin supplement to the basic preterm formula enhances gastrointestinal maturation. The gastrointestinal maturation will be evaluated by the ability of premature infants to achieve complete enteral feeds (150-160cc/kg/day). The insulin concentration supplemented in the study is physiological and within the insulin concentration range present in human breast milk and colostrum.


1. To assess whether insulin enriched formula enhances gastrointestinal maturation by reducing the time required to reach full enteral feed in preterm infants.

2. To assess whether insulin enriched formula enhances gastrointestinal maturation by reducing the number of gastric residuals which are over 2 ml/kg and reducing the number of gastric residual which contain more then 50% of last feeding given content.

3. To assess whether insulin enriched formula reduces number of days to discharge from the neonatal ward.

4. To assess the safety of insulin enriched formula for premature infants by following all adverse events.

5. To assess the weight gain in the preterm infants.

STUDY DESIGN: A Multi-center,two arms, Randomized, Double-blinded placebo controlled

PRODUCT:InsuMeal™ - Insulin Food Supplement for Preterm Infants

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Premature Infants


Insulin supplement, Placebo


Not yet recruiting


Laniado Hospital

Results (where available)

View Results


Published on BioPortfolio: 2014-07-24T14:06:45-0400

Clinical Trials [3162 Associated Clinical Trials listed on BioPortfolio]

Prophylactic Probiotics in Premature Infants

This study tries to determine whether the oral administration of a specific probiotic (good bacteria) in premature infants hospitalized in a neonatal intensive care unit may prevent infect...

Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants

At present, widespread use of the human milk-based caloric supplement (cream) has not occurred, particularly in infants with bronchopulmonary dysplasia (BPD), and further data are needed t...

Nutrition Protocol and Premature Infants' Growth

Nutrition is a major issue for premature infants. Inappropriate nutritional intake during the first weeks of life is responsible for postnatal growth restriction and adverse long-term outc...

Effect of Domperidone on QT Interval in Premature Infants

30 premature infants treated by domperidone upon decision of the attending neonatologist will have a daily recording of electrocardiogram for the first 7 seven days of treatment, and pharm...

Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease

The purpose of this study is to evaluate how easily gas can be taken up by the lung. We are comparing infants born premature 37 weeks. We hope to evaluate the differences between the two g...

PubMed Articles [5190 Associated PubMed Articles listed on BioPortfolio]

The characteristics of premature infants with transient corneal haze.

The etiology of transient corneal haze in premature infants is not known and how it relates to clinical outcomes in premature infants is not clear.

Increasing effort without noticing: A randomized controlled pilot study about the ergogenic placebo effect in endurance athletes and the role of supplement salience.

Previous research shows that endurance performance can be enhanced by placebo ergogenic aids. This study investigates the ergogenic placebo response, which we define as an increase in objective and ph...

Diagnostic value of chest CT combined with x-ray for premature infants with bronchopulmonary dysplasia.

Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in the newborns. Staging of BPD severity does not have a high predictive value for the outcomes. This study was aimed to assess the di...

Antibiotic Overuse in Premature Low-Birth-Weight Infants in a Developing Country.

Neonatal sepsis is a leading cause of child morbidity and mortality, especially in premature and low-birth-weight (LBW) infants. Prompt antibiotic therapy is warranted, but its inappropriate use leads...

Changes in Autonomic Tone in Premature Infants Developing Necrotizing Enterocolitis.

 Necrotizing enterocolitis (NEC) is a complication of prematurity with a high mortality rate. Currently, there are no reliable biomarkers capable of identifying infants at risk for developing NEC. W...

Medical and Biotech [MESH] Definitions

Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE).

A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.

Diseases that occur in PREMATURE INFANTS.

A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.

A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.

More From BioPortfolio on "Insulin Food Supplement for Preterm Infants"

Quick Search


Relevant Topics

Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Searches Linking to this Trial